Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma.
The authors describe a case of an 8-month-old boy with opsoclonus-myoclonus syndrome (OMS) and coincident unresectable neuroblastoma (NB). He achieved a complete remission for NB after 6 courses of standard-dose chemotherapy without significant neurological improvement despite the use of steroids and high-dose immunoglobulin (HIG), administered separately. Only the combined treatment withthese two drugs induced a complete disappearance of neurological symptoms. On the basis of this experience, the authors suggest the association of steroids plus HIG for the treatment of OMS in patients not responsive to conventional first line therapy with steroids.
Veneselli
E
E
Department of Pediatric Neuropsychiatry, University of Genoa, Italy.
Conte
M
M
Biancheri
R
R
Acquaviva
A
A
De Bernardi
B
B
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D007223:Infant; D008297:Male; D009207:Myoclonus / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D009447:Neuroblastoma / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D015835:Ocular Motility Disorders / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D013577:Syndrome
D018931:Antineoplastic Agents, Hormonal; D003907:Dexamethasone